Figure 5.

The relationship of highly mutated genes with various clinical factors in HBV‐related HCC patients. A, The significant frequency of highly mutated genes with different BCLC stages in HBV‐related HCC patients. B, The significant frequency of highly mutated genes in male and female HBV‐related HCC patients. C, The significant frequency of highly mutated genes with or without vascular invasion in HBV‐related HCC patients. D, The significant frequency of highly mutated genes with different ages in HBV‐related HCC patients. E, The significant frequency of highly mutated genes with different AFP levels in HBV‐related HCC patients. F, The significant frequency of highly mutated genes with different tumor sizes in HBV‐related HCC patients